Open access peer-reviewed chapter

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients

By Naoto Takahashi and Masatomo Miura

Submitted: February 15th 2011Reviewed: July 24th 2011Published: January 5th 2012

DOI: 10.5772/27134

Downloaded: 2686

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Naoto Takahashi and Masatomo Miura (January 5th 2012). Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients, Myeloid Leukemia - Clinical Diagnosis and Treatment, Steffen Koschmieder and Utz Krug, IntechOpen, DOI: 10.5772/27134. Available from:

chapter statistics

2686total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Drug- Induced Pneumonitis: A Rare Complication of Imatinib Mesylate Therapy in Patients with Chronic Myeloid Leukemia

By O.V. Lazareva and A.G. Turkina

Related Book

First chapter

BCR-ABL Hits at Mitosis; Implications for Chromosomal Instability, Aneuploidy and Therapeutic Strategy

By Katarzyna Piwocka, Kamila Wolanin, Monika Kusio-Kobialka and Paulina Podszywalow-Bartnicka

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us